Phenyl Bromoacetate is an intermediate used to prepare 1,2,3-triazole derivatives as cannabinoid CB1 receptor antagonists. It is also used in the synthesis of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.